P372: DISMAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER FAILURE OF BOTH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB - W. Macaron; E. Jabbour; M. Konopleva; F. Ravandi; N. Jain; G. Issa; T. Kadia; K. Sasaki; P. Kebriaei; M. Yilmaz; P. Thompson; K. Takahashi; et al. (HemaSphere, 2022)